Natacha Gassenbach - Biogen Chief Affairs

IDP Stock  EUR 152.90  2.90  1.93%   

Insider

Natacha Gassenbach is Chief Affairs of Biogen Inc
Phone617 679 2000
Webhttps://www.biogen.com

Biogen Management Efficiency

The company has return on total asset (ROA) of 0.0778 % which means that it generated a profit of $0.0778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2433 %, meaning that it generated $0.2433 on every $100 dollars invested by stockholders. Biogen's management efficiency ratios could be used to measure how well Biogen manages its routine affairs as well as how well it operates its assets and liabilities.
Biogen Inc has accumulated 6.28 B in total debt with debt to equity ratio (D/E) of 0.72, which is about average as compared to similar companies. Biogen Inc has a current ratio of 2.08, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Biogen until it has trouble settling it off, either with new capital or with free cash flow. So, Biogen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biogen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biogen to invest in growth at high rates of return. When we think about Biogen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Siphamandla MthethwaHarmony Gold Mining
N/A
Arve NilsenEidesvik Offshore ASA
N/A
Petter LonningEidesvik Offshore ASA
N/A
Jared CoetzerHarmony Gold Mining
N/A
BEng BScHarmony Gold Mining
44
BC LLBHarmony Gold Mining
48
Erling LoddenEidesvik Offshore ASA
N/A
BComm BCommHarmony Gold Mining
40
Johannes CAHarmony Gold Mining
50
Lars EngelsenEidesvik Offshore ASA
N/A
Peter SteenkampHarmony Gold Mining
63
Helga CotgroveEidesvik Offshore ASA
N/A
Ellen OttesenEidesvik Offshore ASA
N/A
BA EdHarmony Gold Mining
58
Takayuki SannoSuntory Beverage Food
N/A
Anton BTechHarmony Gold Mining
58
Gitte TalmoEidesvik Offshore ASA
N/A
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts. BIOGEN INC operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 9100 people. Biogen Inc (IDP) is traded on Frankfurt Exchange in Germany and employs 8,725 people.

Management Performance

Biogen Inc Leadership Team

Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Viehbacher, CEO Pres
Robin Kramer, VP Officer
Sanjay Jariwala, VP Medical
Ginger Gregory, Ex Officer
Anabella Villalobos, Head Sciences
Susan Esq, Chief VP
Michael CPA, Ex CFO
Natacha Gassenbach, Chief Affairs
Nicole Murphy, Head Technology
Michael Hencke, Head Relations

Biogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Biogen Stock

When determining whether Biogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biogen Inc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.